In conclusion, we found that the implementation of an SQ insulin-driven protocol for treating DKA was associated with substantial changes in practice, including a significantly decreased need for intensive care and reduced rates of readmission, with no increase in hypoglycemia or mortality. This evidence concerns the gene INS and Hypoglycemia.